Literature DB >> 9711056

[Spectrum of hypereosinophilia syndrome based on 2 clinical case reports].

H Nolte1, U Helmchen.   

Abstract

BACKGROUND: Two severe cases of hypereosinophilic syndrome with cardiopulmonary symptoms, erythema nodosum, eosinophilic ileocolitis and paresthesia are reported. Definition, etiology, pathophysiological mechanisms, types, complications and therapeutic approaches of this relatively rare clinical disorder are discussed on the basis of these two cases. The distinction between eosinophilia and hypereosinophilic syndrome is clearly defined. DIFFERENTIAL DIAGNOSIS: The 2 cases of hypereosinophilic syndrome demonstrate the difficulty to decide whether they represent the idiopathic or the reactive type of hypereosinophilic syndrome. If the assumption is made in favor of the reactive type of hypereosinophilic syndrome the assumed prognosis could eventually be too promising. In case of an assumed idiopathic type of hypereosinophilic syndrome the search for causing factors like allergens could be left out. The decision concerning the type of hypereosinophilic syndrome of the 2 cases reported was made with high probability. In the case of idiopathic hypereosinophilic syndrome, eosinophilic leukemia was excluded by bone marrow biopsy.
CONCLUSION: In order to be able to make a diagnosis it is necessary to search carefully for causing and influencing factors of the hypereosinophilic syndrome such as allergens or medicaments and to eliminate them. The hypereosinophilic syndrome must be put under frequent control in order to avoid complications or to start with therapeutic approaches in time.

Entities:  

Mesh:

Year:  1998        PMID: 9711056     DOI: 10.1007/bf03042639

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  63 in total

Review 1.  Pleuropneumonic reactions to nitrofurantoin.

Authors:  F J Hailey; H W Glascock; W F Hewitt
Journal:  N Engl J Med       Date:  1969-11-13       Impact factor: 91.245

2.  [Eosinophilia myalgia syndrome in administration of L-tryptophan].

Authors:  N Zöllner; M Sorg; K Krüger
Journal:  Klin Wochenschr       Date:  1990-07-17

3.  Successful reduction of endomyocardial fibrosis in a patient with idiopathic hypereosinophilic syndrome. A case report.

Authors:  C Lombardi; C Rusconi; P Faggiano; G Lanzani; C Campana; E Arbustini
Journal:  Angiology       Date:  1995-04       Impact factor: 3.619

Review 4.  Endomyocardial disease and eosinophilia.

Authors:  P V Felice; J Sawicki; J Anto
Journal:  Angiology       Date:  1993-11       Impact factor: 3.619

Review 5.  Increased circulating levels of interleukin-5 in a case of steroid-resistant hypereosinophilic syndrome with ileal involvement. Longcope Firm of the Osler Housestaff.

Authors:  J Fang; M Y Viksman; M Ebisawa; B S Bochner
Journal:  J Allergy Clin Immunol       Date:  1994-07       Impact factor: 10.793

Review 6.  [ANCA-associated forms of vasculitis].

Authors:  U Helmchen; U Kneissler; F Prall
Journal:  Verh Dtsch Ges Pathol       Date:  1996

7.  [Neurologic complications in hypereosinophilia syndrome--a case report].

Authors:  V Otto
Journal:  Fortschr Neurol Psychiatr       Date:  1993-09       Impact factor: 0.752

8.  [Cardiac involvement in the hypereosinophilia syndrome. the importance of echocardiography in the follow-up].

Authors:  T Menzel; H Lambertz; G Rau
Journal:  Dtsch Med Wochenschr       Date:  1992-10-02       Impact factor: 0.628

9.  Cyclosporin for hypereosinophilic syndrome.

Authors:  P Zabel; M Schlaak
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

10.  Multifocal neuropathy with vasculitis in hypereosinophilic syndrome. An entity or drug-induced effect?

Authors:  W Grisold; K Jellinger
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.